Conflicts of Interest
The authors declare no competing interests.
Acknowledgements
We would like to express our sincere gratitude to Guillermo L Chantada,
Ricardo dos Reis, and Martins Fideles dos Santos Neto for their valuable
suggestions and contributions to this scientific article. Their insights
and expertise have greatly enhanced the quality of our work, and we are
truly appreciative of their collaborative spirit and dedication to
advancing scientific knowledge in this
field.
References
1. Pruteanu DP, Olteanu DE,
Cosnarovici R, Mihut E, Nagy V. Genetic predisposition in pediatric
oncology. Med Pharm Rep. 2020;93(4):323-334.
2. Abdolvahabi A, Taylor BW,
Holden RL, et al. Colorimetric and longitudinal analysis of leukocoria
in recreational photographs of children with retinoblastoma. PLoS
One. 2013;8(10):e76677.
3. Bernard A, Xia SZ, Saleh
S, et al. EyeScreen: Development and potential of a novel machine
learning application to detect leukocoria. Ophthalmol Sci.
2022;2(3):100158.
4. Erwenne’ CM, Franc EL. Age
and lateness of referral as determinants of extra- ocular
retinoblastoma. Ophthalmic Paediatrioy and Generics.
1989;10:179-184.
5. Kaliki S, Ji X, Zou Y, et
al. Lag Time between Onset of First Symptom and Treatment of
Retinoblastoma: An International Collaborative Study of 692 Patients
from 10 Countries. doi:10.3390/12
6. Chantada GL.
Retinoblastoma: lessons and challenges from developing countries.
Ellsworth Lecture 2011. Ophthalmic Genet. 2011;32(4):196-203.
7. Mattosinho CC de S,
Grigorovski N, Lucena E, Ferman S, Soares de Moura ATM, Portes AF.
Prediagnostic Intervals in Retinoblastoma: Experience at an Oncology
Center in Brazil. J Glob Oncol. 2017;3(4):323-330.
8. Al-Haddad C, Bashour Z,
Farah L, et al. Establishment of a formal program for retinoblastoma:
Feasibility of clinical coordination across borders and impact on
outcome. Pediatr Blood Cancer. 2019;66(11):e27959.
9. Joseph B, Shanmugam MP,
Srinivasan MK, Kumaramanickavel G. Genetic Testing versus Conventional
Clinical Screening in India. O Mol Diagn. 2004;8(4):237-243.
10. Moher D, Liberati A,
Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for
systematic reviews and meta-analyses: the PRISMA statement. PLoS
Med. 2009;6(7):e1000097.
11. Munn Z, Moola S, Lisy K,
Riitano D, Tufanaru C. Manual for Evidence Synthesis. JBI; 2020.
doi:10.46658/JBIMES-20-06
12. Munn Z, Moola S, Lisy K,
Riitano D, Tufanaru C. Methodological guidance for systematic reviews of
observational epidemiological studies reporting prevalence and
cumulative incidence data. Int J Evid Based Healthc.
2015;13(3):147-153.
13. Joseph B, Madhavan J,
Mamatha G, Ramprasad VL, Gopal L, Kumaramanickavel G. Retinoblastoma: a
diagnostic model for India. Asian Pac J Cancer Prev. 7
2006;7(3):485-488.
14. Guillermo L. Chantada
,Ira J. Dunkel, Paula S. Schaiquevich, Edith L. Grynszpancholc, Jasmine
Francis, Alejandro Ceciliano, Pedro A. Zubizarreta, Adriana C.
Fandi~no ,David H. Abramson. Twenty-Year Collaboration
Between North American and South American Retinoblastoma Programs.American Society of Clinical Oncology. 2016;2(6).
doi:10.1200/JGO.2015.002782
15. Howard SC, Zaidi A, Cao
X, et al. The My Child Matters programme: effect of public-private
partnerships on paediatric cancer care in low-income and middle-income
countries. Lancet Oncol. 2018;19(5):e252-e266.
16. Wilimas JA, Wilson MW,
Haik BG, et al. Development of retinoblastoma programs in Central
America. Pediatr Blood Cancer. 2009;53(1):42-46.
17. Ademola-Popoola DS,
Olatunji VA. Retinal imaging with smartphone. Niger J Clin Pract.
2017;20(3):341-345.
18. Al-Nawaiseh I, Ghanem AQ,
Yousef YA. Familial Retinoblastoma: Raised Awareness Improves Early
Diagnosis and Outcome. J Ophthalmol. 2017;2017:5053961.
19. Kaliki S, Gupta Rathi S,
Patel A. Routine fundus screening of families of children with
retinoblastoma: A prospective study of 131 consecutive families.Retina. 2019;39(7):1326-1332.
20. Khedekar A, Devarajan B,
Ramasamy K, Muthukkaruppan V, Kim U. Smartphone-based application
improves the detection of retinoblastoma. Eye .
2019;33(6):896-901.
21. Vargas-Cuentas NI, Medina
FF, Villarreal KR. System for the Early Detection of Retinoblastoma.2019 IEEE 39th Central America and Panama Convention (CONCAPAN
XXXIX). Published online 2019:1-5.
22. Yousef YA, Alkhoms A,
AlJabari R, et al. Programmed screening for retinoblastoma enhances
early diagnosis and improves management outcome for high-risk children.Ophthalmic Genet. 2020;41(4):308-314.
23. Thirumalairaj K, Abraham
A, Devarajan B, et al. A stepwise strategy for rapid and cost-effective
RB1 screening in Indian retinoblastoma patients. J Hum Genet.
2015;60(9):547-552.
24. Antoneli CBG, Steinhorst
F, Ribeiro K de CB, et al. O papel do pediatra no diagnóstico precoce do
retinoblastoma. Rev Assoc Med Bras. 2004;50(4):400-402.
25. Elfalah M, AlNawaiseh T,
Atoum D, et al. Improving Medical Students’ Awareness About
Retinoblastoma: A Practical Strategy. Clin Ophthalmol.
2022;16:1807-1814.
26. Hill JA, Lee SY, Njambi
L, Corson TW, Dimaras H. Cancer genetics education in a low- to
middle-income country: evaluation of an interactive workshop for
clinicians in Kenya. PLoS One. 2015;10(6):e0129852.
27. Leander C, Fu LC, Peña A,
et al. Impact of an education program on late diagnosis of
retinoblastoma in Honduras. Pediatr Blood Cancer.
2007;49(6):817-819.
28. Hill JA, Kimani K, White
A, et al. Achieving optimal cancer outcomes in East Africa through
multidisciplinary partnership: a case study of the Kenyan National
Retinoblastoma Strategy group. Global Health. 2016;12(1):23.
29. Qaddoumi I, Nawaiseh I,
Mehyar M, et al. Team management, twinning, and telemedicine in
retinoblastoma: a 3-tier approach implemented in the first eye salvage
program in Jordan. Pediatr Blood Cancer. 2008;51(2):241-244.
30. Yousef YA, Al-Nawaiseh I,
Mehyar M, et al. How Telemedicine and Centralized Care Changed the
Natural History of Retinoblastoma in a Developing Country: Analysis of
478 Patients. Ophthalmology. 2021;128(1):130-137.
31. Traore F, Togo B, Sylla
F, et al. Le rétinoblastome : état des lieux au Mali et programme d’aide
au diagnostic précoce, aux traitements et à la réhabilitation.Bull Cancer. 2013;100(2):161-165.
32. Chantada GL, Fandiño AC,
Raslawski EC, et al. Experience with chemoreduction and focal therapy
for intraocular retinoblastoma in a developing country. Pediatr
Blood Cancer. 2005;44(5):455-460.
33. Chantada G, Doz F,
Antoneli CBG, et al. A proposal for an international retinoblastoma
staging system. Pediatr Blood Cancer. 2006;47(6):801-805.
34. Soliman SE, Dimaras H,
Khetan V, et al. Prenatal versus Postnatal Screening for Familial
Retinoblastoma. Ophthalmology. 2016;123(12):2610-2617.
35. Rodriguez-Galindo C,
Wilson MW, Chantada G, et al. Retinoblastoma: One World, One Vision.Pediatrics. 2008;122(3):e763-e770.
36. Leal-Leal C, Flores-Rojo
M, Medina-Sansón A, et al. A multicentre report from the Mexican
Retinoblastoma Group. Br J Ophthalmol. 2004;88(8):1074-1077.
37. CureAll framework: WHO
global initiative for childhood cancer. WHO global initiative for
childhood cancer. Accessed September 1, 2024.
https://www.who.int/publications/i/item/9789240025271
38. Dimaras H, Corson TW,
Cobrinik D, et al. Retinoblastoma. Nat Rev Dis Primers.
2015;1:15021.
39. Ademola-Popoola DS,
Opocher E, Ashwin Reddy M. Contemporary management of retinoblastoma in
the context of a low-resource country. Niger Postgrad Med J.
2019;26(2):69.
40. Nyamori JM, Kimani K,
Njuguna MW, Dimaras H. Retinoblastoma referral pattern in Kenya.Middle East Afr J Ophthalmol. 2014;21(4):321-327.
41. Mattosinho CCDS, Moura
ATMS, Oigman G, Ferman SE, Grigorovski N. Time to diagnosis of
retinoblastoma in Latin America: A systematic review. Pediatr
Hematol Oncol. 2019;36(2):55-72.
42. Jabir AR, Zaheer HA,
Zaheer MA, Zaheer EA, Birdsong R. Detection and Diagnosis of
Retinoblastoma: Can Mobile Devices Be the Next Step Toward Early
Intervention? Cureus. 2022;14(10):e30074.
43. Croswell JM, Ransohoff DF,
Kramer BS. Principles of cancer screening: lessons from history and
study design issues. Semin Oncol. 2010;37(3):202-215.
44. World report on vision. Geneva: World Health Organization; 2019.
Licence: CC BY-NC-SA 3.0 IGO.
45. Leal-Leal CA, Dilliz-Nava
H, Flores-Rojo M, Robles-Castro J. First contact physicians and
retinoblastoma in Mexico. Pediatr Blood Cancer.
2011;57(7):1109-1112.